Oral Oncology
Volume 40, Issue 9 , Pages 910-915 , October 2004

Genomic instability in non-neoplastic oral mucosa cells can predict risk during 4-nitroquinoline 1-oxide-induced rat tongue carcinogenesis

Received 25 March 2004 ,Accepted 22 April 2004.

References 

  1. Magrath I, Litvak J. Cancer in developing countries: opportunity and challenge. J. Natl. Cancer Inst. 1993;85(11):862–874
  2. Xi S, Grandis JR. Gene therapy for the treatment of oral squamous cell carcinoma. J. Dent. Res. 2003;82(1):11–16
  3. Hahn M, Hagedorn G, Kuhlisch E, Schackert HK, Edkelt U. Genetic polymorphisms of drug-metabolizing enzymes and susceptibility to oral cavity cancer. Oral Oncol. 2002;38(5):486–490
  4. Tanaka T, Kohno H, Sakata K, Yamada Y, Hirose Y, Sugie S, et al. Modifying effects of dietary capsaicin and rotenone on 4-nitroquinoline 1-oxide-induced rat tongue carcinogenesis. Carcinogenesis. 2002;23(8):1361–1367
  5. Ohne M, Satoh T, Yamada S, Takai H. Experimental tongue carcinoma of rats induced by oral administration of 4-nitroquinoline 1-oxide (4NQO) in drinking water. Oral Surg. Oral Med. Oral Pathol. 1985;59(6):600–607
  6. Nishimura A. Changes in Bcl-2 and Bax expression in rat tongue during 4-nitroquinoline 1-oxide-induced carcinogenesis. J. Dent. Res. 1999;78(6):1264–1269
  7. Niwa S, Ueno S, Shirasu R. Alteration of pRB expression in the development of rat tongue carcinoma induced by 4-nitroquinoline 1-oxide. Oral Oncol. 2001;37(7):579–585
  8. Okazaki Y, Tanaka Y, Tonogi M, Yamane G. Investigation of environmental factors for diagnosing malignant potential in oral epithelial dysplasia. Oral Oncol. 2002;38(6):562–573
  9. Vered M, Daniel N, Hirshberg A, Dayan D. Histomorphologic and morphometric changes in minor salivary glands of the rat tongue during 4-nitroquinoline 1-oxide-induced carcinogenesis. Oral Oncol. 2003;39(5):491–496
  10. Limoli CL, Kaplan MI, Phillips JW, Adair GM, Morgan WF. Differential induction of chromosomal instability by DNA strand-breaking agents. Cancer Res. 1997;57(18):4048–4056
  11. Califano J, van der Riet P, Westra W, Nawroz H, Clayman G, Piantadosi S, et al. Genetic progression model for head and neck cancer: implications for field cancerization. Cancer Res. 1996;56(24):2488–2492
  12. Tice RR, Agurell E, Anderson D, Burlinson B, Hartmann A, Kobayashi H, et al. Single cell gel/comet assay: guidelines for in vitro and in vivo genetic toxicology testing. Environ. Mol. Mutag. 2000;35(3):206–221
  13. Hartmann A, Agurell E, Beevers C, Brendler-Schwaab S, Burlinson B, Clay P, et al. Recommendations for conducting the in vivo alkaline comet assay. Mutagenesis. 2000;18(1):45–51
  14. Strauss GHS. Non-random cell killing in cryopreservation: implications for performance of the battery of leukocyte tests (BLT) I. Toxic and immunotoxic effects. Mutat. Res. 1991;252(1):1–15
  15. Wiklund SJ, Agurell E. Aspects of design and statistical analysis in the comet assay. Mutagenesis. 2003;18(2):167–175
  16. Nauta JM, Roodenberg JLN, Nikkels PGJ, Witjes MJH, Vermey A. Comparison of epithelial dysplasia––the 4NQO rat palate model and human oral mucosa. Int. J. Oral Maxillofac. Surg. 1995;24(1 Pt1):53–58
  17. Wu X, Lippman SM, Lee JJ, Zhu Y, Wei V, Thomas M, et al. Chromosome instability in lymphocytes: a potential indicator of predisposition to oral premalignant lesions. Cancer Res. 2002;62(10):2813–2818
  18. Hartwell LH, Kastan MB. Cell cycle control and cancer. Science. 1994;266(5192):1821–1828
  19. Sudbo J, Kildal W, Risberg B, Koppang HS, Sudbo A, Danielsen HE, et al. DNA content as a prognostic marker in patients with oral leukoplakias. New Engl. J. Med. 2001;344(17):1270–1278
  20. Sudbo J, Ried T, Bryne M, Kidal W, Danielsen HE, Reith A. Abnormal DNA content predicts the occurence of carcinomas in non-dysplastic oral white patches. Oral Oncol. 2001;37(7):558–565
  21. Gontijo AMMC, Elias FN, Salvadori DMF, Oliveira MLCS, Correa LA, Goldberg J, et al. Single-cell gel (comet) assay detects primary DNA damage in nonneoplastic urothelial cells of smokers and ex-smokers. Cancer Epidemiol. Biomarkers Prevent. 2001;10(9):987–993
  22. Gontijo AMMC, Marcondes JPC, Elias FN, Oliveira MLCS, Alves de Lima RO, Salvadori DMF, et al. DNA damage in cytologically normal urothelium cells of patients with a history of urothelial cell carcinoma. Environ. Mol. Mutag. 2002;40(3):190–199
  23. Schwartz JL, Muscat JE, Baker V, Larios E, Stephenson GD, Guo W, et al. Oral cytology assessment by flow cytometry of DNA adducts, aneuploidy, proliferation and apoptosis show differences between smokers and non-smokers. Oral Oncol. 2003;39(8):842–854
  24. Jackson AL, Loeb LA. The contribution of endogenous sources of DNA damage to the multiple mutations in cancer. Mutat. Res. 2001;477(1–2):7–21
  25. Offer H, Zurer I, Banfalvi G, Reha'k M, Falcovitz M, Milyavsky M, et al. P53 modulates base excision repair activity in a cell cycle-specific manner after genotoxic stress. Cancer Res. 2001;61(1):88–89

PII: S1368-8375(04)00097-1

doi: 10.1016/j.oraloncology.2004.04.010

Oral Oncology
Volume 40, Issue 9 , Pages 910-915 , October 2004

Article Tools

* Image Usage & Resolution